biotech · ALK-positive Non-small Cell Lung Cancer · Biliary Tract Carcinoma
Zelgen Biopharmaceuticals
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Zelgen Biopharmaceuticals clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Kunshan, CN HQ
8 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Kunshan, CN
- Employees
- 8
- Programs
- 3
- Drugs
- 7
- Patents
- 0
Zelgen Biopharmaceuticals projects
0 ClinicalTrials.gov programs sponsored by Zelgen Biopharmaceuticals.
Zelgen Biopharmaceuticals has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Zelgen Biopharmaceuticals have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.